Wouldn’t it be great to find a real blue sky growth story? The kind of opportunity that can ramp from zero to the big leagues and take early-stage investors along for the ride?
A lot of traders applaud when they find just ONE company with that kind of potential. I just heard about a little ground-floor stock that combines TWO home-run themes . . . and it only takes a single whispered word to start the cheering.
That word is “blockstrain.” It’s the marriage of the blockchain technology that runs crypto accounts like bitcoin and the strain that differentiates one breed of plant product from another. If you’ve got your eye on the ball, you can probably connect the dots already.
Long story short, there’s a tiny company called BLOCKstrain Technology Corp. (Ticker is DNAX in Canada only.) They’ve got big plans. It only went public at the end of May so it was young and vulnerable when technology stocks hit a wall a few weeks ago.
But that only created an opportunity to capture this unique double play at a price below what institutional investors paid early on! And from the look of things that opportunity is closing fast:
After all, Goldman Sachs says blockchain is one of the hottest trends around. The word itself sizzles so loudly on Wall Street that the SEC is having to crack down on companies changing their name to take advantage.
BLOCKstrain, on the other hand, is pure blockchain. It isn’t a copycat or me-too play. Applying the blockchain to the world of cannabis strains is what they DO.
Now I know a few people reading this aren’t sure what exactly blockchain really is or how you build a business out of applying it to cannabis strains. That’s OK.
From Blockchain to BLOCKStrain
Blockchain is the computing model that supports cryptocurrencies. It’s more than all the “coins” clogging the market lately. You might love them, but the real power here goes far beyond the latest offerings and forks.
Strip away the jargon and blockchain boils down to crunching so many numbers within a cloud of networked computers that digital “money” is as hard to forge as the real thing.There’s so much processing power built into each link in the data “chain” that it’s practically impossible to break the code.
It’s really just a cybersecurity system that enforces itself. And that self-enforcing structure can authenticate and validate a lot more than the balance in your digital money account.
Kodak is developing blockchain applications that authenticate image files, forcing picture pirates to buy a license. It’s only a hop from there to building copy protection code into songs and movies so Hollywood can sleep better at night.
De Beers has turned to blockchain to track every fleck of diamond dust in its system, from mine to retail store. Again, it’s not hard to make the mental leap to any kind of logistics or inventory management environment . . . slap a chip on the box and log every move it makes around the planet in real time.
A transparent data trail that’s practically unhackable. We might come back to that point later as we explore what Blockstrain can do for the cannabis industry.
But start with one of the most basic challenges facing that industry right now, a “proof of concept” if you like. As you probably know, modern legal cannabis has been bred since ancient times to produce literally thousands of sub-species, each with its own characteristics, active ingredient profile and specialized niche to fill. These are the strains.
Strains can be as distinctive as poodles are different from German shepherds. They’re both “dogs” but the resemblance ends there. Likewise, separate strains of cannabis don’t always have the distinctive green leaves. They look different, smell different and, according to connoisseurs, produce different effects.
Growers and dispensaries make good money creating and promoting exotic strains like craft beers lined up behind a fancy bar. In theory a strain can be proprietary, which gives a farm or retail operation a unique reason to attract a choosy customer. Doctors can prescribe a specific type of plant to capture a different chemical profile that fits their patient’s needs.
And that’s where today’s strains hit a reality wall. There isn’t a whole lot of science behind how the strains are named or what separates them from each other. There’s no genetic registry or database that tracks them all, and even the best efforts to date run on something close to an “honor system” — they’ll tell you what genes are in a particular plant, but have a hard time proving that’s the plant a dispensary is actually selling.
It all makes sense. Cannabis cultivation spent a long time in the regulatory shadows. These farms sat out the age of scientific agriculture and are only now in the first stages of catching up. But the lack of clarity and enforcement can frustrate EVERYONE.
Consumers who want an exotic thrill feel ripped off if they’re just getting the same old Mary Jane. Patients who need a specific molecule mix NEED to make sure they get it. Strain breeders hate it when pirates or amateurs knowingly or accidentally step on their plant’s carefully selected DNA. And the regulators see everything.
BLOCKStrain Technology Corp. brings the trust back to an industry that can’t run on good vibes forever. They validate the DNA, tracking each gene up and down the supply chain from the grow facility to the final consumption point.
This was a “dark market” until recently. Even Canada just voted to legalize last month . . . and now their regulators have until October to make sure everything is compliant. The “Wild West” is over. Every gram in every dispensary needs to be validated.
That’s what BLOCKStrain does. Any switch or glitch is visible. Everybody can see what they’re getting.
An industry that’s grown from zero to $10 billion in recent memory needs that level of trust in order to take things to the next level. Older and more sophisticated consumers who can pay for a luxury product can confirm that’s really what they’re getting. Scientists looking at the molecules have metrics that make Big Pharma research worthwhile.
Want a product that’s been grown in actual dirt using traditional organic farming techniques? BLOCKStrain can confirm that every procedure has been followed on the plants that went into your particular purchase. Want to license your proprietary plant to growers? BLOCKStrain takes care of enforcement and quality control so you can get back to work on the next hot hybrid.
Want to make sure customer reviews of a particular strain aren’t just hot air? Reading between the lines, I think BLOCKStrain can do that too.
Think of all the hard work a mature industry like fine wine had to do . . . to evolve. The commercial applications for cannabis stack up as high as investors can dream right now. And at the end of the day, that’s why we’re here, right?
Management is itching to hit the ground running. They’re serious people. They love the industry but they have deep backgrounds in law, business development and especially technology. We’re talking Microsoft-level expertise.
They want to roll up all the niches they can, segment by segment, easy ones first: licensing, validation, objective metrics that help make everyone get what they want.
In a $10 billion industry, that’s probably worth a few basis points at least. The labs are lining up to pay. That’s MILLIONS of dollars, just as a conservative slice of the overall cash flow. And it’s only the first step in achieving this pure blockchain stock’s real potential.
Mile High and Beyond
If your system can track molecules from roots to retail, you’ve got an ironclad chain of custody. “Shrinkage” in dispensaries can be crippling . . . not to mention a regulatory red flag. When the boss can see where every ounce goes, the data trail makes internal inventory security a whole lot easier.
One day, the strain chain will be able to validate prescriptions and screen customers. Every transaction is logged to show the regulators when (not if) they call. What’s THAT worth?
We haven’t even talked about what BLOCKStrain can do on the payment side. That’s an area dispensaries struggle hard with . . . they’re still shut out of the banks . . . but to be honest, management isn’t even interested in that truly disruptive opportunity right now.
They’ve got too much real meat on their plate to chase pie in the sky. The easy segments come first to get the cash flowing. Then, as they grow, they can REALLY get ambitious. It’s a classic “land and expand” model. It’s a classic because it works.
And investors who somehow find a way to get exposure here at the ground floor will get to enjoy the entire ride. That’s a rare, rare thing right now.
Dirty Wall Street secret: today’s growth portfolios are stuffed with stocks that ended their real exponential expansion phase years or even decades ago. We’re talking about Apple, Facebook, Microsoft, Alphabet, the names many of us grew up with.
They’re world-class companies. But they’re already so massive that they need to keep bolting on $30-$40 billion businesses every year just to move the needle double digits. Their sweetest days of making instant fortunes are behind them.
Blockchain is still ramping up from zero. The whole bitcoin boom is only a warning shot.
Legal cannabis is only starting to join the modern age of intellectual property, supply chain systems, business intelligence. Yet it’s already a $10 billion industry.
BLOCKstrain is at the center of both stories. Keep an eye on this company and its Canadian ticker, DNAX. If you see the potential here, there may not be a lot of chances to take a seat beside the strategic investors who’ve already crowded up to the table.
Disclaimer :
This is a paid advertisement and all individuals should verify all claims and perform their own due diligence on DNAX (and / or any other mentioned companies and / or securities), and read this disclaimer in its entirety.
Stock Talk Today profiles are not a solicitation or recommendation to buy, sell or hold securities. Stock Talk Today is a paid advertiser and is not offering securities for sale. Neither Stock Talk Today nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by Stock Talk Today its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations.
Stock Talk Today does not recommend that the securities profiled should be purchased, sold or held and is not liable for any investment decisions by its readers or subscribers.
Information presented by Stock Talk Today may contain “forward-looking statements ” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance, are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of words such as “expects, ” “will, ” “anticipates,” “estimates,” “believes,” “may,” or by statements indicating that certain actions “may,” “could,” or “might” occur.
THIS SITE IS PROVIDED BY STOCK TALK TODAY ON AN “AS IS” AND “AS AVAILABLE” BASIS. STOCK TALK TODAY MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, AS TO THE OPERATION OF THIS SITE OR THE INFORMATION, CONTENT, MATERIALS, OR PRODUCTS INCLUDED ON THIS SITE. YOU EXPRESSLY AGREE THAT YOUR USE OF THIS SITE IS AT YOUR SOLE RISK.
TO THE FULL EXTENT PERMISSIBLE BY APPLICABLE LAW, STOCK TALK TODAY DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. STOCK TALK TODAY DOES NOT WARRANT THAT THIS SITE, IT’S SERVERS, OR E-MAIL SENT FROM STOCK TALK TODAY ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. STOCK TALK TODAY, ITS MEMBERS, MANAGERS, OWNERS, AGENTS, AND EMPLOYEES WILL NOT BE LIABLE FOR ANY DAMAGES OF ANY KIND ARISING FROM THE USE OF THIS SITE, INCLUDING, BUT NOT LIMITED TO DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, AND CONSEQUENTIAL DAMAGES.
CERTAIN STATE LAWS DO NOT ALLOW LIMITATIONS ON IMPLIED WARRANTIES OR THE EXCLUSION OR LIMITATION OF CERTAIN DAMAGES. IF THESE LAWS APPLY TO YOU, SOME OR ALL OF THE ABOVE DISCLAIMERS, EXCLUSIONS, OR LIMITATIONS MAY NOT APPLY TO YOU, AND YOU MIGHT HAVE ADDITIONAL RIGHTS.
By using Stock Talk Today, you agree, without limitation or qualification, to be bound by, and to comply with, these Terms of Use and any other posted guidelines or rules applicable.
The website contains links to other related World Wide Web Internet sites and resources. Stock Talk Today is not responsible for the availability of these outside resources, or their contents, nor does Stock Talk Today endorse nor is Stock Talk Today responsible for any of the contents, advertising, products or other materials on such sites. Under no circumstances shall Stock Talk Today be held responsible or liable, directly or indirectly, for any loss or damages caused or alleged to have been caused by use of or reliance on any content, goods or services available on such sites. Any concerns regarding any external link should be directed to its respective site administrator or webmaster.
You agree to indemnify and hold Stock Talk Today, its officers, directors, owners, agents and employees, harmless from any claim or demand, including reasonable attorneys fees, made by any third party due to or arising out of your use of the website, the violation of these Terms of Use by you, or the infringement by you, or other user of the website using your computer, of any intellectual property or other right of any person or entity. We reserve the right, at our own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification.
Stock Talk Today is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).
We publish the Information on our website, stocktalktoday.com and in newsletters, text message alerts, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer and / or third party paying us. Our publication of the Information is known as a “Campaign”. This information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. Typically, the trading volume and price of a Profiled Issuer’s securities increases after the information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer trading losses if they purchase the securities of a Profiled Issuer late in a Campaign. We are paid to advertise the Profiled Issuers, Blockstrain Technology Corp. Stock Talk Today has been hired by Blockstrain Technology Corp. , for a period beginning on Nov 15, 2018 to publicly disseminate information about (DNAX) via website and email. We have been compensated $20,000. We will update any changes to our compensation. We own zero shares of (DNAX).
Third Parties paying us to market the Profiled Issuer we believe intend to sell their shares they hold while we tell investors to purchase during the Campaign. European Electric Metals is a penny stock that was illiquid (little to no trading volume) prior to our Campaign, and therefore these securities are subject to wide fluctuations in trading price and volume. During the Campaign the trading volume and price of the securities of each Profile Issuer will likely increase significantly because of the media exposure. When the Campaign ends, the volume and price of the Profiled Issuer will likely decrease dramatically. As a result, investors who purchase during the Campaign and hold shares of the Profiled Issuer when the Campaign ends will probably lose most, if not all, of their investment.
The Information we publish in the Campaign is only a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful and / or reliable. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness and / or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities.
All information in our Campaign is publicly available information from 3rd party sources and / or the Profiled Issuers and/or the 3rd parties that hire us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, Yahoo, Bing, the Securities and Exchange Commission’s Edgar database or other available public sources.
We select the stocks we profile and / or pick as we are compensated to advertise them. If an investor relies solely on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision.
The source of our compensation varies depending upon the particular circumstances of the Campaign. In certain cases, we are compensated by the Profiled Issuers, third party shareholders, and / or other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities.
We make no warranty and / or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation.
We are not, and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following: an independent adviser or consultant; a fortune teller; an investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal and / or state level; a broker-dealer or an individual acting in the capacity of a registered representative or broker; a stock picker; a securities trading expert; a securities researcher or analyst; a financial planner or one who engages in financial planning; a provider of stock recommendations; a provider of advice about buy, sell or hold recommendations as to specific securities; or an agent offering or securities for sale or soliciting their purchase.
There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer.
We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest. Third parties that have hired us and own shares will sell these shares while we tell investors to purchase, and this selling of the Profiled Issuer’s securities will likely cause investors to suffer losses.
Our publication of the Information involves actual and material conflicts of interest including but not limited to the fact that we receive monetary compensation in exchange for publishing the (favorable) Information about the Profiled Issuers; and we do not publish any negative information, whatsoever, about the Profiled Issuers; in addition to the fact that while we do not own the Profiled Issuer’s securities, the third parties that hired us do, and intend to sell all of these securities during the Campaign while we publish favorable information that instructs investors to purchase, and this selling of the Profiled Issuer’s securities will likely cause investors to suffer losses.
We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions and / or errors in the Information and we are not responsible for actions taken by any person who relies upon the Information.
We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and / or investment adviser(s). An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products and / or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, Yahoo, Bing, OTC Markets, NASDAQ, NYSE, www.sec.gov or other available public sources.
We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose my compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell my own shares. The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns.
Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.
We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.
If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.
The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.
The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.
You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.
When 3rd parties that hire us acquire, purchase and / or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit themselves to make substantial profits while investors who purchase during the Campaign experience significant losses.
The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.
We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and may fail to disclose their compensation to you.
If a Profiled Issuer is a SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at www.otcmarkets.com, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions.
If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and/or government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies.
The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.otcmarkets.com or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the OTCMarkets.com; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.org. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at otcmarkets.com.
Stock Talk Today, reserves the right, at its sole discretion, to change, modify, add and/ or remove all or part of this Disclaimer and / or Terms of Use at any time.
